Home
About
Overview
Team
Directors
Advisors
Our Approach
Overview
Therapeutic Approach
Discovery Platform
Pipeline
Overview
ST101
β-Catenin Antagonist
cJun Antagonist
cMyc Antagonist
FoxP3 Antagonist
Expanded Access
Partnering
Careers
News & Events
Press Releases
Events
Publications
Presentations
Email Alerts
Contact
Press Releases
News & Events
News & Events
Press Releases
Events
Publications
Presentations
Email Alerts
Year
All Years
2022
2021
2020
2019
2018
2017
2016
Jul 12, 2016 9:36am EDT
Sapience Therapeutics Completes $22.5 Million Series A Financing
Previous
1
2
3
4
5
6
